Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings

<p>IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) &#8212; Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced the company will present a poster titled “Selective peroxisome proliferator-activated receptor (PPAR) delta (δ) agonist, mavodelpar, improves cellular bioenergetics in [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/reneo-pharmaceuticals-announces-poster-presentation-at-upcoming-scientific-meetings/">Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>